Camtech Diagnostics, Singapore

Camthrax Biothreat Detector
Camtech Diagnostics, Singapore

Featured Date: 26th November 2015


Established in 2011, Camtech Diagnostics (Camtech), offers innovative diagnostic solutions to the clinical, biodefense and food safety industries. It operates on advanced technology platforms such as microfluidics and biosensing. The company has been recognized with various public grants. Camtech has established collaborative relationships with academic research institutes such as SIMTech (Singapore Institute of Manufacturing technology) under A*STAR and companies such as CapitalBio Corporation, Veritide Ltd, Knight Photonics Ltd.

The technology focus of Camtech is in integrating sensors with microfluidic platforms. These are suitable for colorimetric, wireless, UV, and fluorescence platforms. Based on these proprietary platforms, the company offers customized solutions to diagnostic companies to develop portable label-free detection devices, which can be applied to a broad range of end-use segments including research, clinical diagnostics, industrial process monitoring, and environmental monitoring.

The company also offers several in-house developed diagnostic products. The product portfolio of the company comprises of CE-marked diagnostic PCR system and microarray kits for the diagnosis of tuberculosis, HPV, and TB-induced hearing loss. The PCR products include RT Cycler™, which is a real-time PCR thermal cycler compatible with SYBR® and Taqman® probes and qPCR detection kit for Tuberculosis. Microarray kits include mycobacteria identification array kit and TB multi drug resistance (MDR) array kit. The mycobacteria identification array kit is designed on a single chip and can identify to up to 17 mycobacterial species.

Other products of Camtech include Camthrax Biothreat Detector and CamPrep system. Camthrax is a hand-held device for detection of dangerous bacterial spores such as Anthrax, Tetanus, and Clostridium. The CamPrep system is a technology workstation used for the development of point-of-care diagnostic tests with the aid of custom-designed microfluidic chips. The company has fabrication, prototyping, and manufacturing facilities for developing polymer-on-chip devices.